Guest Family Physician Commentaries

References

1. ↵
   Cummings DM, Larsen LC, Doherty L, Lea SC, Holbert D. Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus. J Am Board Fam Med 2011; 24(4): 391–8.

   OpenUrl
2. ↵
   Huff LS, Zittleman L, DeAlleaume L, et al. What keeps patients from adhering to a home blood pressure program? J Am Board Fam Med 2011; 24(4): 370–9.

   OpenUrl
3. ↵
   Hsu C-H, Wang J-Y, Chen Y-L, et al. Relationships between alanine aminotransferase levels, abnormal liver echogenicity, and metabolic syndrome. J Am Board Fam Med 2011; 24(4): 407–14.

   OpenUrl
4. ↵
   Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report 2009; (13): 1–7.

   OpenUrl
5. ↵
   Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109(4): 551–6.

   OpenUrl
6. ↵
   Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43(1): 70–5.

   OpenUrl
7. ↵
   Bayard M, Bailey B, Acharya D, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2011; 24(4): 422–8.

   OpenUrl
8. ↵
   Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010; 6(6): 337–46.

   OpenUrl